G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2009
12/10/2009	US20090305291 method and a microdevice for the identification and/or quantification of an analyte in a biological sample
12/10/2009	US20090305290 Lateral flow nucleic acid detector
12/10/2009	US20090305289 Screening method to identify protective substances for the treatment of neurodegenerative and/or ischaemic diseases
12/10/2009	US20090305286 Method for the Identification of Suitable Fragmentation Sites in a Reporter Protein
12/10/2009	US20090305283 thermostable FEN-1 endonuclease and a polymerase; site-specific nuclease cleavage by a variety of enzymes
12/10/2009	US20090305278 Sequence determination in confined regions
12/10/2009	US20090305276 Method for Predicting Skin Sensitizing Activity of Compounds
12/10/2009	US20090305275 DNAs AND PROTEINS OR PEPTIDES SPECIFIC TO BACTERIA OF THE SPECIES NEISSERIA MENINGITIDIS, PROCESS FOR OBTAINING THEM AND THEIR BIOLOGICAL USES
12/10/2009	US20090305272 Method of characterizing endogenous polynucleotide-polypeptide interactions
12/10/2009	US20090305267 Microbial markers of inflammatory bowel disease
12/10/2009	US20090305266 Test for ovarian cancer by detecting abnormality in fancd2 pathway
12/10/2009	US20090305265 Interleukin-33 (il-33) for the diagnosis and prognosis of cardiovascular disease
12/10/2009	US20090305259 Early Diagnosis of Congenital Abnormalities in the Offspring of Diabetic Mothers
12/10/2009	US20090305255 Substrate Protein for M-Phase Kinase and use Thereof
12/10/2009	US20090305235 Novel Targets For The Identification Of Antibiotics That Are Not Susceptible To Antibiotic Resistance
12/10/2009	US20090305231 Sensitive Immunoassays Using Coated Nanoparticles
12/10/2009	US20090305230 Real Time Detection of Molecules, Cells and Particles Using Photonic Bandgap Structures
12/10/2009	US20090305228 Potentiation of Apoptosis by Monoclonal Antibodies
12/10/2009	US20090305226 Biomolecular Recognition of Crystal Defects
12/10/2009	US20090305225 Inhibition of Creatine Uptake to Promote Weight Loss
12/10/2009	US20090304858 Phosphoadenylyl Sulfate Reductase Gene and Use Thereof
12/10/2009	US20090304778 Diagnostics and Methods for Removal and Detection of Interferents
12/10/2009	US20090304765 R-ras activity in vascular regulation
12/10/2009	US20090304746 Inducing cellar immune responses to hepatitis C virus using peptide and nucleic acid compositions
12/10/2009	US20090304744 Methods of enhancing immune response in the intradermal compartment and compounds useful thereof
12/10/2009	US20090304736 Novel tumor antigens elicit anti-tumor humoral immune reactions in a subset of patients with polycythemia vera
12/10/2009	US20090304731 Recombinant antigens for diagnosis and prevention of spotted fever rickettsiae
12/10/2009	US20090304728 Tem8 gene, expression forms and diagnostic and therapeutic uses thereof
12/10/2009	US20090304722 Chlamydia trachomatis antigens for vaccine and diagnostic use
12/10/2009	US20090304719 Activatable binding polypeptides and methods of identification and use thereof
12/10/2009	US20090304714 IKKi Inhibitor Therapies and Screening Methods, and Related IKKi Diagnostics
12/10/2009	US20090304712 Neuronal Cell Death Inhibitor and Screening Method
12/10/2009	US20090304710 Novel anti-cd38 antibodies for the treatment of cancer
12/10/2009	US20090304709 Modulators of p-selectin glycoprotein ligand 1
12/10/2009	US20090304708 Preparation for the Prevention and/or Treatment of a Tissue Change of Mesenchymal Origin
12/10/2009	US20090304704 Methods for diagnosing and predicting non-alcoholic steatohepatitis (nash)
12/10/2009	US20090304703 Compositions and methods for the diagnosis and treatment of immune disorders
12/10/2009	US20090304702 Gene expressed in prostate cancer and methods of use
12/10/2009	US20090304700 Conformation specific antibodies that bind trefoil factors
12/10/2009	US20090304689 Methods for the identification of polypeptide antigens associated with disorders involving aberrant cell proliferation and compositions useful for the treatment of such disorders
12/10/2009	US20090304683 Soluble Fragments of The Sars-Cov Spike Glycoprotein
12/10/2009	US20090304680 Diagnosis and treatment of kawasaki disease
12/10/2009	US20090304667 Method of Regulating Mammalian Target-of-Rapamycin Activity by Interaction Between Phospholipase D and RHEB
12/10/2009	US20090304653 Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions
12/10/2009	US20090304625 Modulators of cardiac cell hypertrophy and hyperplasia
12/10/2009	US20090304596 Methods for Predicting Psychotropic Drugs Which Elicit Weight Gain
12/10/2009	US20090304594 Methods for Predicting Treatment Response Based On the Expression Profiles of Protein and Transcription Biomarkers
12/10/2009	US20090304580 Anti-Pancreatic Cancer Antibodies
12/10/2009	US20090304579 Cancerous Disease Modifying Antibodies
12/10/2009	US20090304578 Cancerous Disease Modifying Antibodies
12/10/2009	US20090304577 Peptides for Treatment and Diagnosis of Autoimmune Disease
12/10/2009	US20090304550 Analytical tool
12/10/2009	US20090304549 Microfabricated devices with coated or modified surface and method of making same
12/10/2009	US20090304547 Portable analytical device
12/10/2009	US20090303462 Correlation technique for analysis of clinical condition
12/10/2009	US20090301936 Composition and use thereof
12/10/2009	US20090301884 Electrophoretic analysis system having in-situ calibration
12/10/2009	US20090301564 Upon excitation, one carrier confined to core and other carrier confined to overcoating; band gaps; photovoltaic devices, photoconductors
12/10/2009	US20090301382 Monitoring System Based on Etching of Metals
12/10/2009	US20090301234 Apparatus and method for measuring the surface flux of a soil gas component
12/10/2009	US20090301176 Microelectromechanical System Comprising a Deformable Portion and a Stress Sensor
12/10/2009	US20090301175 Waste water immersion probe
12/10/2009	US20090301169 Selective membranes/thin films for analytical applications
12/10/2009	US20090300987 Mixture to add odour to an odourless combustible gas
12/10/2009	DE102008049462A1 Device for detecting substance of fluid, has piezo-acoustic thin film resonator, piezo-electric layer, and electrode layer that is arranged on piezo-electric layer
12/10/2009	DE102008048618B3 Verfahren zum laser-induzierten Transport von Materialien von einem transparenten Trägersubstrat A method of laser-induced transport of materials from a transparent support substrate
12/10/2009	DE102008027630A1 Transportabler Pneumotachograph zur Messung von Bestandteilen des Exspirationsvolumens The portable pneumotachograph for measuring components of an expiration volume
12/10/2009	DE102008026803A1 Analysis system for determining substances in liquids, comprises a light-impermeable container, which has light source, sample rack for receiving sample vessels and opening for object lens of digital photo camera, and a fastening device
12/10/2009	DE102008025127A1 State sensor has sensor housing, vibration element arranged partially in sensor housing, and mass element arranged in sensor housing
12/10/2009	CA2764611A1 Methods and instrumentation for during-synthesis monitoring of polymer functional evolution
12/10/2009	CA2726975A1 Noninvasive measurement of carotenoids in biological tissue
12/10/2009	CA2726885A1 Sirna of human osteopontin
12/10/2009	CA2726817A1 Identification and use of prognostic and predictive markers in cancer treatment
12/10/2009	CA2726811A1 Survival predictor for diffuse large b cell lymphoma
12/10/2009	CA2726804A1 Xbp1, cd138, and cs1 peptides
12/10/2009	CA2726741A1 Method of assaying physiologically active substance of biological origin, kit for assaying physiologically active substance of biological origin and apparatus for assaying physiologically active substance of biological origin
12/10/2009	CA2726739A1 Assay reader, device and method for measuring hcg
12/10/2009	CA2726641A1 Nasal formulations of insulin
12/10/2009	CA2726598A1 Controllable assembly and disassembly of nanoparticle systems via protein and dna agents
12/10/2009	CA2726563A1 Protein biomarkers for in vitro testing of developmental toxicity and embryotoxicity of chemical substances
12/10/2009	CA2726531A1 Compositions and methods for classifying lung cancer and prognosing lung cancer survival
12/10/2009	CA2726481A1 Detecting infection in reduced pressure wound treatment
12/10/2009	CA2726426A1 Diffuse large b-cell lymphoma markers and uses therefor
12/10/2009	CA2726345A1 Interleukin-1 alpha abs and methods of use
12/10/2009	CA2725634A1 Biomarker for assessing response to chymase treatment
12/10/2009	CA2723939A1 User interface for testing device
12/09/2009	EP2131200A1 A marker for graft failure and mortality
12/09/2009	EP2131199A1 Biomarker for osteoarthritis and/or other ageing-related diseases, and use thereof
12/09/2009	EP2131198A2 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays
12/09/2009	EP2131197A1 Device for determining an analyte in a fluid sample and analysis device
12/09/2009	EP2131196A1 Detection of analytes on a flow-through biosensor
12/09/2009	EP2131195A1 Assays of molecular or subcellular proximity using depolarization after resonance energy transfer (DARET)
12/09/2009	EP2131194A1 Improved electrochemical-sensor design
12/09/2009	EP2131193A1 Method for examination of activity of anti-cancer agent employing reduction in expression level of gene as measure
12/09/2009	EP2131189A1 Method and device using nanoporous membrane for the voltammetric detection and quantification of heavy metal ions in a fluid.
12/09/2009	EP2131186A1 Device for measuring the purity of ultrapure water
12/09/2009	EP2131182A1 Lubricant degradation detector and bearing with the detector
12/09/2009	EP2131181A2 Method for the determination of the total acid number and naphthenic acid number of petroleum, petroleum cuts and petroleum emulsions of water-in-oil type by mid-infrared spectroscopy
12/09/2009	EP2131179A2 An apparatus and method for evaluating a hydrocarbon to determine the propensity for coke formation
12/09/2009	EP2130926A2 Phage microarray profiling of the humoral response to disease

1 ... 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 ... 3937